Perioperative Pediatric Blood Transfusion Therapy

August 20, 2020 updated by: Dr. Florian Piekarski, Johann Wolfgang Goethe University Hospital

Analysis of Perioperative Pediatric Blood Transfusion Therapy

The present retrospective study analyses perioperative haemotherapy in children and adolescents at the University Hospital Frankfurt.

Study Overview

Status

Completed

Conditions

Detailed Description

In the center of the analyses are the perioperative consumption of transfused red cell concentrates, platelet concentrates and frozen fresh plasma in children and adolescents. The distribution by subject area is also examined, demographic distribution and indicators on transfusion. With the introduction of the Patient Blood Management for adults at the University Hospital in 2013 have become potentially also result in changes in transfusion practice in children, which should also be investigated.

Study Type

Observational

Enrollment (Actual)

14248

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • NRW
      • Frankfurt, NRW, Germany, 60598
        • Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 17 years (Child)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Children undergoing surgery

Description

Inclusion Criteria:

  • Children and adolescents <18 years
  • Hospital admission
  • Operation

Exclusion Criteria:

- none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Transfused red cell concentrates
Time Frame: 01.01.2010 - 31.12.2019
Quantity of transfused red cell concentrates
01.01.2010 - 31.12.2019
Platelet concentrates transfused
Time Frame: 01.01.2010 - 31.12.2019
Quantity of Platelet concentrates transfused
01.01.2010 - 31.12.2019

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2020

Primary Completion (Actual)

August 1, 2020

Study Completion (Actual)

August 1, 2020

Study Registration Dates

First Submitted

April 9, 2020

First Submitted That Met QC Criteria

April 14, 2020

First Posted (Actual)

April 16, 2020

Study Record Updates

Last Update Posted (Actual)

August 24, 2020

Last Update Submitted That Met QC Criteria

August 20, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • KGU_FP_2020_CA11

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transfusion

3
Subscribe